Creating tools to analyze glucose data for hospitalized diabetes patients
Developing statistical analysis and prediction tools for continuous glucose monitoring (CGM) use in hospitalized patients with diabetes
This study is working on better ways to manage diabetes for patients in the hospital by using special tools to analyze real-time blood sugar data, helping doctors make smarter decisions to keep your glucose levels stable and reduce complications.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11026374 on NIH RePORTER |
What this research studies
This research focuses on improving the management of diabetes in hospitalized patients by developing advanced statistical tools for continuous glucose monitoring (CGM). It aims to analyze the data collected from CGM devices, which provide real-time glucose levels, to enhance glycemic control and reduce complications. The project will address current limitations in data analysis methods, ensuring that healthcare providers can make informed decisions based on accurate and timely information. By leveraging CGM technology, the research seeks to optimize diabetes care in hospital settings.
Who could benefit from this research
Good fit: Ideal candidates for this research are hospitalized adults with diabetes who require continuous glucose monitoring.
Not a fit: Patients who are not hospitalized or do not have diabetes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better glucose management for hospitalized patients with diabetes, reducing complications and improving overall health outcomes.
How similar studies have performed: Previous research has shown promise in using continuous glucose monitoring for diabetes management, indicating that this approach could be effective in hospital settings as well.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Peng, Limin — Emory University
- Study coordinator: Peng, Limin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.